BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31977861)

  • 1. Significant association between methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: A meta-analysis update.
    Li Y; Zhu H; Liu M; Zeng Z; Zeng Y; Xu X; Ye M
    Medicine (Baltimore); 2020 Jan; 99(4):e18720. PubMed ID: 31977861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.
    Fu LY; Dai LM; Li XG; Zhang K; Bai Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():56-61. PubMed ID: 24192663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with genetic susceptibility to polycystic ovary syndrome: A PRISMA-compliant meta-analysis.
    Zhu X; Hong X; Chen L; Xuan Y; Huang K; Wang B
    Gene; 2019 Nov; 719():144079. PubMed ID: 31454542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.
    Xiong Y; Bian C; Lin X; Wang X; Xu K; Zhao X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in polycystic ovary syndrome risk.
    Wu JB; Zhai JF; Yang J
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28081274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome.
    Nsrallah AA; Abd-El Fatah AH; Ahmed HS
    J Gene Med; 2019 Apr; 21(4):e3076. PubMed ID: 30743312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome].
    Qi Q; Zhang H; Yu M; Wang X; Wang Z; Xu L; Wang J; Mu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):400-4. PubMed ID: 26037361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an association between the development of metabolic syndrome in PCOS patients and the C677T MTHFR gene polymorphism?
    Ożegowska K; Bogacz A; Bartkowiak-Wieczorek J; Seremak-Mrozikiewicz A; Pawelczyk L
    Ginekol Pol; 2016; 87(4):246-53. PubMed ID: 27321094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome.
    Choi SW; Gu BH; Ramakrishna S; Park JM; Baek KH
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):85-8. PubMed ID: 19427093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MTHFR C677T polymorphism on homocysteine and vitamin D in women with polycystic ovary syndrome.
    Zhao J; Li X; Chen Q
    Gene; 2024 Aug; 919():148504. PubMed ID: 38670392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between maternal, fetal and paternal MTHFR gene C677T and A1298C polymorphisms and risk of recurrent pregnancy loss: a comprehensive evaluation.
    Yang Y; Luo Y; Yuan J; Tang Y; Xiong L; Xu M; Rao X; Liu H
    Arch Gynecol Obstet; 2016 Jun; 293(6):1197-211. PubMed ID: 26530235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Bagos PG
    Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTHFR C677T, A1298C and MS A2756G Gene Polymorphisms and Male Infertility Risk in a Chinese Population: A Meta-Analysis.
    Ren Z; Ren P; Yang B; Fang K; Ren S; Liao J; Liu S; Liu L; Peng Z; Dong Q
    PLoS One; 2017; 12(1):e0169789. PubMed ID: 28081209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis on associations of FTO, MTHFR and TCF7L2 polymorphisms with polycystic ovary syndrome.
    Wang X; Wang K; Yan J; Wu M
    Genomics; 2020 Mar; 112(2):1516-1521. PubMed ID: 31470081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility.
    Meng Y; Liu X; Ma K; Zhang L; Lu M; Zhao M; Guan MX; Qin G
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1020. PubMed ID: 31663297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between methylenetetrahydrofolate reductase C677T polymorphism and diabetic retinopathy: A meta-analysis in multiethnic groups.
    Chen D; Wang J; Dan Z; Shen X; Ci D
    Ophthalmic Genet; 2018 Apr; 39(2):200-207. PubMed ID: 29182429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Wu YL; Ding XX; Sun YH; Yang HY; Sun L
    J Neurol Sci; 2013 Dec; 335(1-2):14-21. PubMed ID: 24064257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.
    Ma C; Liu Y; Zhang W; Liu P
    Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.